ஜாக்குலின் கெல்லரர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜாக்குலின் கெல்லரர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜாக்குலின் கெல்லரர் Today - Breaking & Trending Today

ClearPoint Neuro, Inc. (CLPT) Q1 2021 Earnings Call Transcript


Operator
Greetings. Welcome to ClearPoint Neuro Inc. s first-quarter financial results conference call. [Operator instructions] Please note, this conference is being recorded. Comments made on this call may include statements that are forward-looking within the meaning of the securities laws.
These forward-looking statements may include, without limitation, statements related to anticipated industry trends, the company s plans, prospects, and strategies, both preliminary and projected, and management s expectations, beliefs, estimates, or projections regarding future results of operations. Actual results or trends could differ materially. The company undertakes no obligation to revise forward-looking statements for new information or future events. For more information, please refer to the company s annual report on Form 10-K for the year ended December 31, 2020, which has been filed with the Securities and Exchange Commission, and the company s quarterly report on Form 10 ....

United States , Andrew Dsilva , Michael Litka , Joe Burnett , Danilo Dalessandro , Andrew Dsilvab Riley , Jacqueline Keller , Exchange Commission , Welcome To Clearpoint Neuro Inc , Capital Pte Ltd , Clearpoint Neuro Inc , Clearpoint Neuro , Maestro Brain Model , Smartframe Array , Western Europe , Andrewd Silva , Maestro Brain , Frank Takkinen , Lake Street Capital , Street Capital Markets , Capital Pte , Citi Small , ஒன்றுபட்டது மாநிலங்களில் , ஆண்ட்ரூ ட்சில்வா , ஓஹோ பர்னெட் , டானிலோ டாப்லெஸ்ஸான்றோ ,

ClearPoint Neuro Launches Proposed Public Offering of Common Stock


ClearPoint Neuro Launches Proposed Public Offering of Common Stock
February 18, 2021 16:35 ET
| Source:
ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc.
Irvine, California, UNITED STATES
IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today the commencement of a proposed underwritten public offering of its shares of common stock. All the shares will be offered by the Company. The Company also expects to grant the underwriters a 30-day option to purchase additional shares of common stock in an amount of up to 15% of the number of shares sold in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. ....

United States , Danilo Dalessandro , Jacqueline Keller , Capital Markets , Clearpoint Neuro Inc , Company Quarterly Reports On Form , Exchange Commission , Company Annual Report On Form , Prospectus Department , B Riley Securities Inc , Applications Of The Company , Company Smartflow , Point Neuro , Lake Street Capital Markets , Neuro Navigation System , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Chief Financial , Vice President , Clearpoint Neuro , Nasdaq Clpt , ஒன்றுபட்டது மாநிலங்களில் , டானிலோ டாப்லெஸ்ஸான்றோ , ஜாக்குலின் கெல்லரர் , மூலதனம் சந்தைகள் ,

ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips
ClearPoint Neuro, Inc.February 18, 2021 GMT
Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint ‘Maestro™’ Brain Model by 2022
IRVINE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a worldwide license and research agreement with Philips, a global leader in health technology, to commercialize the ClearPoint ‘Maestro’ Brain Model. The company expects the first-generation anatomical segment analysis tool to be launched in 2022. ....

United States , Joe Burnett , Jacqueline Keller , Erik Pastink , Company Clearpoint Neuro Navigation System , Clearpoint Neuro Inc , Company Annual Report On Form , Exchange Commission , Applications Of The Company , Company Quarterly Report On Form , Company Smartflow , Program Leader Healthtech Ip Licensing At Philips , Enable Clearpoint , Brain Model , Point Neuro , Maestro Brain , Program Leader Healthtech , Clearpoint Neuro , Philips Brain Model , Clearpoint Neuro Navigation System , Annual Report , Quarterly Report , Vice President , Licensing Agreements , Corporate News , Covid 19 Pandemic ,